Antibody shows promise in Crohn's disease

BMJ 1997; 314 doi: (Published 01 March 1997) Cite this as: BMJ 1997;314:623
  1. Jacqui Wise
  1. BMJ

    A genetically engineered antibody may be a promising new treatment for Crohn's disease, according to a small randomised controlled trial.

    Previous studies have suggested raised concentrations of tumour necrosis factor alpha, which stimulates the immune system, are associated …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial